Health care policy. Reforming off-label promotion to enhance orphan disease treatment.
Liang
Bryan A
BA
Institute of Health Law Studies, California Western School of Law, San Diego, CA 92101, USA. baliang@alum.mit.edu
Mackey
Tim
T
D017277:Drug Approval; D006291:Health Policy; D006801:Humans; D007880:Legislation, Drug; D056687:Off-Label Use / Q000331:legislation & jurisprudence; D009965:Orphan Drug Production / Q000331:legislation & jurisprudence; D011358:Product Surveillance, Postmarketing; D035583:Rare Diseases / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration